Holders over time
- SGRY
- ELV
| Quarter | SGRY | ELV |
|---|---|---|
| Q3 2020 | 1 holders, $3.2m | 30 holders, $15.0bn |
| Q4 2020 | none listed holders, n.a. | 29 holders, $16.7bn |
| Q1 2021 | 1 holders, $271k | 25 holders, $18.6bn |
| Q2 2021 | 2 holders, $484m | 30 holders, $19.4bn |
| Q3 2021 | 3 holders, $14m | 26 holders, $18.5bn |
| Q4 2021 | 5 holders, $668m | 29 holders, $23.3bn |
| Q1 2022 | 5 holders, $778m | 31 holders, $23.9bn |
| Q2 2022 | 4 holders, $470m | 32 holders, $23.3bn |
| Q3 2022 | 3 holders, $67m | 34 holders, $22.6bn |
| Q4 2022 | 5 holders, $928m | 34 holders, $25.5bn |
| Q1 2023 | 6 holders, $1.2bn | 39 holders, $22.5bn |
| Q2 2023 | 6 holders, $1.5bn | 38 holders, $20.6bn |
| Q3 2023 | 6 holders, $958m | 34 holders, $19.8bn |
| Q4 2023 | 6 holders, $1.0bn | 36 holders, $20.3bn |
| Q1 2024 | 8 holders, $1.1bn | 35 holders, $21.3bn |
| Q2 2024 | 8 holders, $469m | 33 holders, $22.1bn |
| Q3 2024 | 8 holders, $1.1bn | 30 holders, $20.2bn |
| Q4 2024 | 7 holders, $428m | 32 holders, $15.9bn |
| Q1 2025 | 7 holders, $504m | 28 holders, $17.1bn |
| Q2 2025 | 6 holders, $380m | 27 holders, $14.8bn |
| Q3 2025 | 7 holders, $375m | 27 holders, $12.7bn |
| Q4 2025 | 5 holders, $316m | 25 holders, $17.0bn |
| Q1 2026 | 5 holders, $230m | 26 holders, $13.6bn |
| Q2 2026 | 4 holders, $311m | 28 holders, $17.7bn |
Surgery Partners Inc
- Holders
- 8
- Reported value
- $469m
- Buyers
- 4
- Sellers
- 3
Breadth +1 among 94 comparable managers.
Elevance Health Inc Formerly
- Holders
- 33
- Reported value
- $22.1bn
- Buyers
- 14
- Sellers
- 21
Breadth -7 among 94 comparable managers.
Who holds both, Q2 2024
Both (7)
ExodusPoint Capital Management LP, First Eagle Investment Management LLC, Holocene Advisors LP, Janus Henderson Group Ltd, Moore Capital Management LP, Point72 Asset Management LP, Wellington Management Group LLP
Only SGRY (1)
Only ELV (26)
AllianceBernstein LP, AQR Capital Management LLC, Arrowstreet Capital LP, Artisan Partners LP, Baillie Gifford & Co, Balyasny Asset Management LLC, Brevan Howard Capital Management LP, Bridgewater Associates LP, D. E. Shaw & Co., D1 Capital Partners LP, Dodge & Cox, Eisler Capital Management Ltd, Fidelity (FMR LLC), Glenview Capital Management LLC, Invesco Ltd, Jane Street Group LLC, Man Group PLC, Marshall Wace LLP, MFS Investment Management, Millennium Management LLC, Neuberger Berman Group LLC, Ruane Cunniff & Goldfarb LP, T. Rowe Price Associates Inc, Two Sigma Investments LP, Voloridge Investment Management LLC, and 1 more
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. Buyers and sellers count comparable managers (those that filed both quarters) by shares, so a rise in value with no rise in shares is the price. Large books are listed to their largest positions. These are 95 tracked managers, not the institutional market.